Literature DB >> 28993872

A novel mutation of VAPB in one Chinese familial amyotrophic lateral sclerosis pedigree and its clinical characteristics.

Yi-Min Sun1, Yi Dong1, Jian Wang1, Jia-Hong Lu1, Yan Chen2, Jian-Jun Wu3.   

Abstract

The mutation of vesicle-associated membrane protein-associated protein B (VAPB) was proved to cause family amyotrophic lateral sclerosis (FALS). Only two mutations of VAPB associated with ALS have been reported (p.Pro56Ser and p.Thr46Ile). Here we reported a Chinese Han FALS family caused by a novel VAPB point mutation. The clinical materials of one Chinese Han FALS family were collected. The genetic analysis was carried out by target sequencing and further verified by Sanger sequencing. One novel mutation of c.167C>A (p.Pro56His) on VAPB was found in the proband. The age at onset of the proband was 48 with the onset symptoms of weakness in the right arm, followed by progressive limb and trunk weakness with decreased deep-tendon reflexes, muscular cramps and fasciculation. But the disease duration was more than 15 years. He was under the tracheotomy for 1 year at last visit. Electromyography showed widespread acute and chronic neurogenic damages. His mother presented weakness in her limbs in 50 s and died 15 years later. One of his younger sisters diagnosed as ALS for 6 years also carried the same mutation. She presented the similar symptoms on 41. No dominant upper motor neuron sign was showed. The clinical features were similar to the patients carrying the known mutation of p.Pro56Ser. A novel mutation of VAPB was found in one Chinese Han FALS pedigree. The affected patients presented a much slower progression and the lesions were limited in lower motor neurons.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Chinese; Mutation; Vesicle-associated membrane protein-associated protein B

Mesh:

Substances:

Year:  2017        PMID: 28993872     DOI: 10.1007/s00415-017-8628-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS.

Authors:  Ching-Paio Tsai; Bing-Wen Soong; Kon-Ping Lin; Pang-Hsien Tu; Jer-Li Lin; Yi-Chung Lee
Journal:  Neurobiol Aging       Date:  2010-05-15       Impact factor: 4.673

2.  A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population.

Authors:  Agnes L Nishimura; Ammar Al-Chalabi; Mayana Zatz
Journal:  Hum Genet       Date:  2005-09-27       Impact factor: 4.132

3.  The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case.

Authors:  A D Funke; M Esser; A Krüttgen; J Weis; M Mitne-Neto; M Lazar; A L Nishimura; A D Sperfeld; P Trillenberg; J Senderek; M Krasnianski; M Zatz; S Zierz; M Deschauer
Journal:  Clin Genet       Date:  2010-03       Impact factor: 4.438

4.  Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Hajer El Oussini; Valérie Bercier; François Gros-Louis; Paul N Valdmanis; Jonathan McDearmid; Inge A Mejier; Patrick A Dion; Nicolas Dupre; David Hollinger; Jérome Sinniger; Sylvie Dirrig-Grosch; William Camu; Vincent Meininger; Jean-Philippe Loeffler; Frédérique René; Pierre Drapeau; Guy A Rouleau; Luc Dupuis
Journal:  Hum Mol Genet       Date:  2013-02-26       Impact factor: 6.150

Review 5.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

6.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

7.  Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients with Wilson disease.

Authors:  Zhi-Ying Wu; Min-Ting Lin; Shen-Xing Murong; Ning Wang
Journal:  Arch Neurol       Date:  2003-05

8.  New VAPB deletion variant and exclusion of VAPB mutations in familial ALS.

Authors:  J E Landers; A L Leclerc; L Shi; A Virkud; T Cho; M M Maxwell; A F Henry; M Polak; J D Glass; T J Kwiatkowski; A Al-Chalabi; C E Shaw; P N Leigh; I Rodriguez-Leyza; D McKenna-Yasek; P C Sapp; R H Brown
Journal:  Neurology       Date:  2008-03-05       Impact factor: 9.910

9.  No association between VAPB mutations and familial or sporadic ALS in Sweden, Portugal and Iceland.

Authors:  Caroline Ingre; Susana Pinto; Anna Birve; Rayomand Press; Olof Danielsson; Mamede de Carvalho; Grétar Guđmundsson; Peter M Andersen
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-08-23       Impact factor: 4.092

Review 10.  Autophagy and Neurodegeneration: Insights from a Cultured Cell Model of ALS.

Authors:  Francesca Navone; Paola Genevini; Nica Borgese
Journal:  Cells       Date:  2015-08-06       Impact factor: 6.600

View more
  3 in total

Review 1.  Autophagy Dysfunction in ALS: from Transport to Protein Degradation.

Authors:  Marta Cozzi; Veronica Ferrari
Journal:  J Mol Neurosci       Date:  2022-06-16       Impact factor: 2.866

Review 2.  VAP Proteins - From Organelle Tethers to Pathogenic Host Interactors and Their Role in Neuronal Disease.

Authors:  Suzan Kors; Joseph L Costello; Michael Schrader
Journal:  Front Cell Dev Biol       Date:  2022-06-08

3.  Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration.

Authors:  Danyllo Oliveira; Sergio Verjovski-Almeida; Mayana Zatz
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.